New ESC Guidelines: CKD Screening for Heart Patients
The latest ESC guidelines advocate for chronic kidney disease screening in cardiovascular patients to enhance care and treatment outcomes.
CKD screening is now mandatory for all cardiovascular patients.
Early detection can improve treatment and reduce complications.
Coordination between cardiology and nephrology is essential.
The European Society of Cardiology (ESC) has released new guidelines recommending chronic kidney disease (CKD) screening for all patients diagnosed with cardiovascular disease. This initiative aims to enhance the management of both CKD and cardiovascular conditions, recognizing the significant overlap between the two diseases. With an estimated 100 million people affected by CKD in Europe, early identification is crucial to mitigate risks and improve patient outcomes.
The guidelines emphasize routine screening that includes assessing glomerular filtration rate and urine albumin-to-creatinine ratio. The acronym STAMP—Screen, Triage, Address CKD Risk, Modify CVD Management, and Plan Health Services—highlights the systematic approach to managing these interconnected health issues. By implementing evidence-based treatments and fostering collaboration between cardiology and nephrology, the ESC aims to reduce the burden of CKD and cardiovascular disease on patients and healthcare systems.
